Normal Th1 development following long-term therapeutic blockade of CD154-CD40 in experimental autoimmune encephalomyelitis
J. Clin. Invest. Laurence M. Howard, et al. 109:233
doi:10.1172/JCI14374 [Go to this article.]

Problems with a PDF?